Literature DB >> 11113182

p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias.

Y J Li1, R R Higgins, B J Pak, R A Shivdasani, P A Ney, M Archer, Y Ben-David.   

Abstract

In previous studies, we identified a common site of retroviral integration designated Fli-2 in Friend murine leukemia virus (F-MuLV)-induced erythroleukemia cell lines. Insertion of F-MuLV at the Fli-2 locus, which was associated with the loss of the second allele, resulted in the inactivation of the erythroid cell- and megakaryocyte-specific gene p45(NFE2). Frequent disruption of p45(NFE2) due to proviral insertion suggests a role for this transcription factor in the progression of Friend virus-induced erythroleukemias. To assess this possibility, erythroleukemia was induced by F-MuLV in p45(NFE2) mutant mice. Since p45(NFE2) homozygous mice mostly die at birth, erythroleukemia was induced in +/- and +/+ mice. We demonstrate that +/- mice succumb to the disease moderately but significantly faster than +/+ mice. In addition, the spleens of +/- mice were significantly larger than those of +/+ mice. Of the 37 tumors generated from the +/- and +/+ mice, 10 gave rise to cell lines, all of which were derived from +/- mice. Establishment in culture was associated with the loss of the remaining wild-type p45(NFE2) allele in 9 of 10 of these cell lines. The loss of a functional p45(NFE2) in these cell lines was associated with a marked reduction in globin gene expression. Expression of wild-type p45(NFE2) in the nonproducer erythroleukemic cells resulted in reduced cell growth and restored the expression of globin genes. Similarly, the expression of p45(NFE2) in these cells also slows tumor growth in vivo. These results indicate that p45(NFE2) functions as an inhibitor of erythroid cell growth and that perturbation of its expression contributes to the progression of Friend erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11113182      PMCID: PMC88781          DOI: 10.1128/MCB.21.1.73-80.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  Globin gene regulation and switching: circa 1990.

Authors:  S H Orkin
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.

Authors:  F Moreau-Gachelin; A Tavitian; P Tambourin
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

3.  Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.

Authors:  J R Jenkins; K Rudge; S Redmond; A Wade-Evans
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

4.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus.

Authors:  M Mowat; A Cheng; N Kimura; A Bernstein; S Benchimol
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

5.  Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.

Authors:  J Levin; J P Peng; G R Baker; J L Villeval; P Lecine; S A Burstein; R A Shivdasani
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

6.  Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles.

Authors:  D G Munroe; J W Peacock; S Benchimol
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes.

Authors:  V Chow; Y Ben-David; A Bernstein; S Benchimol; M Mowat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

8.  Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.

Authors:  Y Ben-David; E B Giddens; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2.

Authors:  R A Shivdasani; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  Detailed analysis of the site 3 region of the human beta-globin dominant control region.

Authors:  D Talbot; S Philipsen; P Fraser; F Grosveld
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  8 in total

Review 1.  Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells.

Authors:  Jadwiga J Gasiorek; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2015-02-27       Impact factor: 9.261

2.  Fenretinide targets chronic myeloid leukemia stem/progenitor cells by regulation of redox signaling.

Authors:  Yanzhi Du; Yuan Xia; Xiaoling Pan; Zi Chen; Aihua Wang; Kankan Wang; Junmin Li; Ji Zhang
Journal:  Antioxid Redox Signal       Date:  2013-10-24       Impact factor: 8.401

3.  Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.

Authors:  Jonas Samuel Jutzi; Titiksha Basu; Maximilian Pellmann; Sandra Kaiser; Doris Steinemann; Mathijs A Sanders; Adil S A Hinai; Annelieke Zeilemaker; Sarolta Bojtine Kovacs; Christoph Koellerer; Jenny Ostendorp; Konrad Aumann; Wei Wang; Emmanuel Raffoux; Bruno Cassinat; Lars Bullinger; Brigitte Schlegelberger; Peter J M Valk; Heike Luise Pahl
Journal:  Blood       Date:  2019-02-12       Impact factor: 22.113

4.  JNK-mediated turnover and stabilization of the transcription factor p45/NF-E2 during differentiation of murine erythroleukemia cells.

Authors:  Tung-Liang Lee; Yu-Chiau Shyu; Pang-Hung Hsu; Chiung-Wen Chang; Shau-Ching Wen; Wei-Yuan Hsiao; Ming-Daw Tsai; Che-Kun James Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

5.  Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair.

Authors:  Myriam Alcalay; Natalia Meani; Vania Gelmetti; Anna Fantozzi; Marta Fagioli; Annette Orleth; Daniela Riganelli; Carla Sebastiani; Enrico Cappelli; Cristina Casciari; Maria Teresa Sciurpi; Angela Rosa Mariano; Simone Paolo Minardi; Lucilla Luzi; Heiko Muller; Pier Paolo Di Fiore; Guido Frosina; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Acetylcholinesterase supports anchorage independence in colon cancer.

Authors:  Moyeenuddin Syed; Cecilia Fenoglio-Preiser; Kenneth A Skau; Georg F Weber
Journal:  Clin Exp Metastasis       Date:  2008-07-09       Impact factor: 5.150

7.  Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis.

Authors:  Jeroen Melief; Marie Orre; Koen Bossers; Corbert G van Eden; Karianne G Schuurman; Matthew R J Mason; Joost Verhaagen; Jörg Hamann; Inge Huitinga
Journal:  Acta Neuropathol Commun       Date:  2019-04-25       Impact factor: 7.801

8.  MPN patients harbor recurrent truncating mutations in transcription factor NF-E2.

Authors:  Jonas S Jutzi; Ruzhica Bogeska; Gorica Nikoloski; Corina A Schmid; Thalia S Seeger; Frank Stegelmann; Sven Schwemmers; Albert Gründer; Jan C Peeken; Monika Gothwal; Julius Wehrle; Konrad Aumann; Kamar Hamdi; Christine Dierks; Wei Kamar Wang; Konstanze Döhner; Joop H Jansen; Heike L Pahl
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.